Shakya Akhilesh Kumar, Mallick Buddhadev, Nandakumar Kutty Selva
Whitacre College of Engineering, Texas Tech University, Lubbock, TX 79409, USA.
Department of Zoology, Raniganj Girls College, Bardhaman 713358, West Bengal, India.
Vaccines (Basel). 2023 May 27;11(6):1031. doi: 10.3390/vaccines11061031.
Oral immune tolerance is a physiological process to achieve tolerance against autoimmunity by oral ingestion of self-antigen(s) or other therapeutics. At the cellular level, oral tolerance suppresses autoimmune diseases by activating FoxP-positive and -negative regulatory T cells (Tregs) and/or causing clonal anergy or deletion of autoreactive T cells, affecting B cell tolerance. However, oral delivery of antigens/biologics is challenging due to their instability in the harsh environment of the gastrointestinal (GI) tract. Several antigen/drug delivery tools and approaches, including micro/nanoparticles and transgenic plant-based delivery systems, have been explored to demonstrate oral immune tolerance for different autoimmune diseases successfully. However, despite the effectiveness, variation in results, dose optimization, and undesirable immune system activation are the limitations of the oral approach to further advancement. From this perspective, the current review discusses the oral tolerance phenomenon, cellular mechanisms, antigen delivery tools and strategies, and its challenges.
口服免疫耐受是一种通过口服自身抗原或其他治疗药物来实现对自身免疫耐受的生理过程。在细胞水平上,口服耐受通过激活FoxP阳性和阴性调节性T细胞(Tregs)和/或导致自身反应性T细胞的克隆无能或缺失来抑制自身免疫性疾病,从而影响B细胞耐受。然而,由于抗原/生物制剂在胃肠道(GI)的恶劣环境中不稳定,口服递送具有挑战性。已经探索了几种抗原/药物递送工具和方法,包括微/纳米颗粒和基于转基因植物的递送系统,以成功证明针对不同自身免疫性疾病的口服免疫耐受。然而,尽管有效,但结果的差异、剂量优化以及不良的免疫系统激活是口服方法进一步发展的局限性。从这个角度来看,本综述讨论了口服耐受现象、细胞机制抗原递送工具和策略及其挑战。